Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 203   

Articles published

SNY 52.34 +0.67 (1.30%)
price chart
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Lyxumia (lixisenatide) for the treatment of type 2 diabetes is once-daily GLP-1 from Sanofi's (SNY) stable. It is a potential head to head competitor to Novo Nordisk's (NVO) Victoza ($2.1b - 2013 annual sales).
DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY ...
Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Related articles »  
Sanofi SA (ADR) (NYSE:SNY) In For Interesting Times
Boston, MA, 03/31/2014 (usastockreports)- Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Stocks in the Spotlight - Edwards Lifesciences Corp(NYSE:EW), Sanofi SA (ADR ...
Sanofi SA (ADR)(NYSE:SNY) recently declared that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the second quarter its supplemental Biologics License Application (sBLA) seeking ...
Notable Movers - Sanofi SA (ADR) (NYSE:SNY), Thermo Fisher Scientific Inc ...
Las Vegas, NV - 07 April 2014 - (Tech Sonian) - Sanofi SA (ADR) (NYSE:SNY) declared that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel� (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular ...
Even simple pregnancy tests can run into problems
Providing a superb example of the ever-changing biomedical landscape for even the most mundane of diagnostics, researchers at Washington University School of Medicine find that some commonly-used urine pregnancy tests lose their negative predictive ...
Related articles »  
NYSE unusual Volume: Sanofi SA (NYSE:SNY), Hawaiian Electric Industries ...
Sanofi SA (ADR) (NYSE:SNY) seems to be in for a bumpy ride. On the one hand there is the imminent patent expiry of Lantus in 2015.
Healthcare Active runners: Teva Pharmaceutical Industries (NYSE:TEVA ...  Tech News
Related articles »  
Notable Stocks: Xenith Bankshares (NASDAQ:XBKS), Sanofi SA (NYSE:SNY ...
Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs.
Related articles »  
Investor's Alert � Insulet Corporation (NASDAQ:PODD), Hospira, Inc. (NYSE ...
Sanofi SA (ADR) (NYSE:SNY) posted that the U.S. FDA has enlarged the permitted age indication of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of ...
Related articles »  
Large Cap Unusual Volume: TD Ameritrade Holding (NYSE:AMTD), Anadarko ...
Sanofi SA (ADR) (NYSE:SNY) is so confident that it has already spent EUR 300 million at a facility near Lyon, France and has started producing the drug since July 2013, and is ready to sell from late 2015 subject to regulatory approval.